Immediate Impact
56 standout
Citing Papers
Single test-based diagnosis of multiple cancer types using Exosome-SERS-AI for early stage cancers
2023 Standout
Improved Outcomes with Enzalutamide in Biochemically Recurrent Prostate Cancer
2023 Standout
Works of M.D. Mason being referenced
What is the optimal systemic treatment of men with metastatic, hormone-naive prostate cancer? A STOPCAP systematic review and network meta-analysis
2018
Preparation of human ovarian cancer ascites-derived exosomes for a clinical trial
2005
Author Peers
| Author | Last Decade | Papers | Cites | |||||
|---|---|---|---|---|---|---|---|---|
| M.D. Mason | 246 | 45 | 11 | 101 | 99 | 9 | 357 | |
| Charles R. Sikes | 261 | 22 | 2 | 72 | 122 | 12 | 401 | |
| Anne Moxhon | 180 | 31 | 1 | 39 | 102 | 8 | 318 | |
| Jyotirmoy Dey | 198 | 7 | 10 | 38 | 48 | 11 | 385 | |
| T. Waldron | 175 | 10 | 4 | 20 | 95 | 10 | 314 | |
| Casely Ago | 138 | 18 | 1 | 23 | 61 | 6 | 320 | |
| Yunyi Kong | 203 | 32 | 2 | 84 | 111 | 14 | 321 | |
| Shuncheng Miao | 152 | 8 | 148 | 218 | 12 | 339 | ||
| Octavio A. Armas | 260 | 16 | 4 | 42 | 54 | 12 | 392 | |
| S A Bartow | 59 | 20 | 105 | 88 | 7 | 410 | ||
| Federico Pierella | 118 | 19 | 3 | 160 | 204 | 7 | 346 |
All Works
Loading papers...